期刊文献+

盐酸特比萘芬乳膏中盐酸特比萘芬的含量测定

下载PDF
导出
摘要 目的:总结盐酸特比萘芬乳膏含量的测定方法。方法:采用高效液相色谱法对盐酸特比萘芬乳膏中的盐酸特比萘芬含量进行测定。结果:盐酸特比萘芬在0.0803~0.3213mg.ml-1的浓度范围内线性关系良好,其相关系数为0.9998,平均回收率为100.0%,RSD值为0.30%。结论:采用高效液相色谱法测定盐酸特比萘芬乳膏中盐酸特比萘芬的含量具有准确、精密和稳定等优点。若将此方法应用于制药行业,则可有助于对盐酸特比萘芬乳膏的质量控制。
出处 《求医问药(下半月刊)》 2012年第5期678-679,共2页 Seek Medical and Ask The Medicine
  • 相关文献

参考文献2

二级参考文献33

  • 1国家药品监督管理局.药品注册管理办法(试行),2002:31.
  • 2国家药品监督管理局药品审评中心:中药、天然药物局部刺激性和溶血性研究技术指导原则.2004:15-16.
  • 3国家药品监督管理局药品审评中心:中药、天然药物免疫毒性(过敏性、光变态反应)研究的技术指导原则,2004:17-19.
  • 4Mock M, Monod M, Baudraz-Rosselet F, et al. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.Dermatology, 1998, 197 (4) :361-367.
  • 5Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol,2001,39(1) :91 -95.
  • 6Fuller LC, Smith CH, Cerio R, et al. A randomized comparison of 4weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol, 2001, 144(2) :321-327.
  • 7Filho ST, Cuce LC, Foss NT, et al. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks. J Eur Acad Dermatol Venereol, 1998, 11(2):141-146.
  • 8Koumantaki E, Kakourou T, Rallis E, et al. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol, 2001, 18(4):339-342.
  • 9Gupta AK, Adam P. Terbinafine pulse therapy is effective in tinea capitis. Pediatr Dermatol, 1998, 15(1) :56-58.
  • 10McClellan K J, Wiseman LR, Markham A. Terbinafine. An update of its use in superficial mycoses. Drugs, 1999, 58 (1) :179-202.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部